HC Wainwright restated their buy rating on shares of Prima Biomed Ltd. (NASDAQ:PBMD) in a research note released on Sunday, Analyst Ratings.Net reports. They currently have a $3.00 price target on the stock.

Prima Biomed (NASDAQ:PBMD) opened at 0.9525 on Friday. The company has a 50 day moving average of $1.06 and a 200-day moving average of $1.17. Prima Biomed has a one year low of $0.42 and a one year high of $6.48. The stock’s market capitalization is $62.68 million.

A number of other analysts have also commented on PBMD. FBR & Co. started coverage on Prima Biomed in a research note on Thursday, December 3rd. They issued an outperform rating and a $6.00 price target for the company. Roth Capital started coverage on Prima Biomed in a research note on Wednesday, December 30th. They issued a buy rating and a $6.00 price target for the company.

12 Month Chart for NASDAQ:PBMD

Frustrated with your broker? Are you tired of paying high fees? Do you feel like you are getting ripped off by your stock broker? It's time for a change. Find out which brokerage is best for your personal trading style at the InvestorPlace Broker Center. Compare brokers at a glance in the InvestorPlace Broker Center (Click Here).

Receive News & Ratings for Prima Biomed Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prima Biomed Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.